MedCity News February 26, 2025
For GLP-1 receptor agonists specifically, adherence challenges are a major concern, as these medications require long-term use to achieve meaningful health benefits in chronic conditions like diabetes and obesity.
For patients managing chronic conditions, medication adherence plays a crucial role in successful treatment. However, adherence rates are alarmingly low, with only about 50% of patients consistently following prescribed regimens. This lack of adherence contributes to the estimated $500 billion in avoidable healthcare costs and 125,000 preventable deaths annually in the United States.
To set the stage, two chronic conditions, diabetes and obesity are growing health concerns in the United States, and globally. There are around 537 million people living with diabetes worldwide, with only 15% of patients in good...
Today's Sponsors
Today's Sponsor